next-generation sequencing
OtherUse next-generation sequencing to test germline mutation.
NCT Number: NCT03046849
The purpose of this study is to find out the proportion of patients diagnosed with Lynch syndrome in colorectal cacner patients meeting Chinese Lynch syndrome criteria. Besides, this study is aimed to analyze the clinical characteristics and germline mutation of Lynch syndrome in Chinese population.
Looking for future studies?
Notify MeAll sexes
Observational
Jiangsu Province Hospital, Nanjing, Jiangsu, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
For probands, the inclusion criteria: all of the following three points should be satisfied:
Chinese Lynch syndrome criteria:
In a pedigree, there were at least 2 patients with histological-proven colorectal cancer, and among these, at least two patients are first-degree relatives of each other. Besides, any one of the following three points should be satisfied in the pedigree:
A. at least one patients with multiple primary colorectal carcinoma/adenoma, either synchronously or metachronously.
B. at least one colorectal cancer diagnosed before 50 years old. C. in the pedigree, at least one patient diagnosed with other Lynch syndrome associated cancer (ie, gastric, endometrial, small bowel, ureter, or renal-pelvic, ovarian and hepatobiliary cancers).
For probands, the exclusion criteria:
With at least one blood relative with known pathogenic germline mutation(s).
For blood relatives verifying germline mutation, the inclusion criteria: all of the following three points should be satisfied:
For blood relatives verifying germline mutation, the exclusion criteria:
Blood relatives who refuse to test.
Use next-generation sequencing to test germline mutation.
Time frame: Upon completion of study, on average 2 years.
Pathogenic germline mutation using next-generation sequencing with a targeted panel.
Time frame: Upon completion of study, on average 2 years.
Variant of uncertain significance using next-generation sequencing with a targeted panel.
Second Affiliated Hospital, School of Medicine, Zhejiang University
Other
Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Colorectal Cancer Patients Meeting Chinese Lynch Syndrome Criteria: An Open-label and Multi-center Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06126120
Colonic Diseases, Colorectal Neoplasms
London, United Kingdom
View Trial DetailsNCT06654128
Colonic Diseases, Colorectal Neoplasms
Ramat Gan, Israel
View Trial DetailsNCT03832985
Adnexal Diseases, Breast Diseases
Danville, Pennsylvania, United States
View Trial DetailsNCT04407611
Adnexal Diseases, Breast Diseases
Boston, Massachusetts, United States
View Trial Details